tirzepatide 2022 FDA Grants a New Indication for Obesity Management FDA confirms tirzepatide shortage is

GIP/GLP-1 ift Reseptr Hedeflemesinin Aklamas Tirzepatid Tozu'nun Yaratc yaklam, normalde yemek sonras glikoz reaksiyonlarn kontrol eden iki inkretin yolunu birletirir

There were no statistically significant differences between groups

I had heard there were more affordable options, and I felt like I should explore my options

NHS availability Both medications are available through NHS specialist weight management services (Tier 3 and Tier 4), but access remains limited: Eligibility for specialist services typically requires a BMI of 35 or above (or 30 or above with weight-related health conditions) Previous documented attempts at weight loss are usually required Waiting times vary significantly by region From April 2026, some GP practices can also prescribe Mounjaro for weight management, though this rollout is phased and starts with the highest clinical need (for example, a BMI of 40 or above with several weight-related conditions) Given these limitations, many eligible patients opt for private treatment

Plus, it gives you peace of mind, knowing your practice is compliant and protected